Day: November 12, 2024

Schivo announces strategic recapitalisation from Five Arrows as MML exits
Schivo, the leading global player in outsourced contract development and manufacturing for healthcare OEMs primarily in the medical device and life sciences spaces, is delighted to announce a new investment by Five Arrows, the alternative assets arm of Rothschild & Co. This transaction allows MML Growth Capital Partners Ireland to successfully exit our minority position in the company.

View news articles by year

20242023202220212020201920182017201620152014

MML investor portal logins

For investors in MML Ireland Fund I, MML Ireland Fund II & MML Fund VI

For investors in MML Fund VII